TSCAN THERAPEUTICS, INC. Other Non-Current Liabilities
TSCAN THERAPEUTICS, INC. (TCRX) had Other Non-Current Liabilities of $278.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-03-04
- 2025-09-30: Other Liabilities, Noncurrent $278.00K.
- 2025-06-30: Other Liabilities, Noncurrent $113.00K.
- 2025-03-31: Other Liabilities, Noncurrent $124.00K.
- 2024-12-31: Other Liabilities, Noncurrent $135.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2025-09-30 | $278.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $113.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $124.00K 10-Q · filed 2025-05-06 |
| 2024-12-31 | $135.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | $146.00K 10-Q · filed 2024-11-12 |
| 2023-09-30 | $12.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $24.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $36.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $49.00K 10-K · filed 2024-03-06 |
| 2022-09-30 | $97.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $97.00K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $97.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $97.00K 10-K · filed 2023-03-08 |
| 2021-09-30 | $236.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $238.00K 10-Q · filed 2021-08-19 |
| 2020-12-31 | $238.00K 10-K · filed 2022-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B |